Literature DB >> 24421250

CALR mutation studies in chronic neutrophilic leukemia.

Terra L Lasho1, Michelle A Elliott, Animesh Pardanani, Ayalew Tefferi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24421250     DOI： 10.1002/ajh.23665

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  16 in total

Review 1.  Epidemiology of MPN: what do we know?

Authors:  L A Anderson; M F McMullin
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

2.  Analysis of calreticulin mutations in Chinese patients with essential thrombocythemia: clinical implications in diagnosis, prognosis and treatment.

Authors:  R Fu; M Xuan; Y Zhou; T Sun; J Bai; Z Cao; L Zhang; H Li; D Zhang; X Zhang; C Lv; F Xue; X Liu; R Yang; L Zhang
Journal:  Leukemia       Date:  2014-04-15       Impact factor: 11.528

3.  Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations.

Authors:  Hajnalka Andrikovics; Tunde Krahling; Katalin Balassa; Gabriella Halm; Andras Bors; Magdalena Koszarska; Arpad Batai; Janos Dolgos; Judit Csomor; Miklos Egyed; Andrea Sipos; Peter Remenyi; Attila Tordai; Tamas Masszi
Journal:  Haematologica       Date:  2014-06-03       Impact factor: 9.941

4.  Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.

Authors:  Sa A Wang; Robert P Hasserjian; Patricia S Fox; Heesun J Rogers; Julia T Geyer; Devon Chabot-Richards; Elizabeth Weinzierl; Joseph Hatem; Jesse Jaso; Rashmi Kanagal-Shamanna; Francesco C Stingo; Keyur P Patel; Meenakshi Mehrotra; Carlos Bueso-Ramos; Ken H Young; Courtney D Dinardo; Srdan Verstovsek; Ramon V Tiu; Adam Bagg; Eric D Hsi; Daniel A Arber; Kathryn Foucar; Raja Luthra; Attilio Orazi
Journal:  Blood       Date:  2014-03-13       Impact factor: 22.113

5.  Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value.

Authors:  A M Vannucchi; G Rotunno; N Bartalucci; G Raugei; V Carrai; M Balliu; C Mannarelli; A Pacilli; L Calabresi; R Fjerza; L Pieri; A Bosi; R Manfredini; P Guglielmelli
Journal:  Leukemia       Date:  2014-03-12       Impact factor: 11.528

6.  Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysis.

Authors:  K-H Lim; Y-C Chang; C Gon-Shen Chen; H-C Lin; W-T Wang; Y-H Chiang; H-I Cheng; N-W Su; J Lin; Y-F Chang; M-C Chang; R-K Hsieh; Y-Y Kuo; W-C Chou
Journal:  Blood Cancer J       Date:  2015-03-20       Impact factor: 11.037

7.  CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia.

Authors:  Yajuan Cui; Bing Li; Robert Peter Gale; Qian Jiang; Zefeng Xu; Tiejun Qin; Peihong Zhang; Yue Zhang; Zhijian Xiao
Journal:  J Hematol Oncol       Date:  2014-10-15       Impact factor: 17.388

Review 8.  Chronic Neutrophilic Leukemia: A Literature Review of the Rare Myeloproliferative Pathology.

Authors:  Vishwanath Anil; Harpreet Gosal; Harsimran Kaur; Hyginus Chakwop Ngassa; Khaled A Elmenawi; Lubna Mohammed
Journal:  Cureus       Date:  2021-06-03

Review 9.  Chronic neutrophilic leukemia: a clinical perspective.

Authors:  Juliane Menezes; Juan Cruz Cigudosa
Journal:  Onco Targets Ther       Date:  2015-09-01       Impact factor: 4.147

Review 10.  Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia.

Authors:  Bing Li; Robert Peter Gale; Zhijian Xiao
Journal:  J Hematol Oncol       Date:  2014-12-12       Impact factor: 17.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.